Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
George England has resigned as CEO and a member of the Board of Directors of Global Vision Holdings, Inc., effective October 16, 2026. The company appointed Jean Jacques Sunier, a former Executive Director at Julius Baer Group, as the new CEO and principal executive officer. Compensation arrangements for Mr. Sunier have not yet been finalized and will be disclosed in a future filing.
Galaxy Gaming, Inc. appointed gaming industry veteran John M. Boushy to its Board of Directors as a Class II Director, effective October 21, 2026. Mr. Boushy, who has over 45 years of experience including leadership roles at Harrah’s and Ameristar Casinos, succeeds Meredith Brill, who resigned from the Board effective October 20, 2026.
Entravision appointed Brian Krzanich (former Intel CEO) and Gary Ferrera to its Board of Directors, effective October 14, 2026. Simultaneously, the company announced the resignation of Fehmi Zeko effective October 23, 2026, and that Gilbert Vasquez will not stand for re-election at the 2027 Annual Meeting.
Jonathan Maurer, Co-CEO of OPAL Fuels, has announced his planned retirement effective March 31, 2027. Following his departure, Adam Comora will transition from Co-CEO to become the company's sole Chief Executive Officer, while Maurer will remain as a Senior Advisor to support the transition.
Huntington Ingalls Industries (HII) elected former President and CEO C. Michael Petters to its Board of Directors, effective October 19, 2026. Petters, who led the company from its 2011 spin-off until 2022, will serve on the Cybersecurity and Finance Committees. The company also increased the size of its board from eleven to twelve members.
Entravision Communications Corporation appointed Gary Ferrera and Brian Krzanich to its Board of Directors, effective October 14, 2026. The Board was expanded from seven to nine members to accommodate the new independent directors, who will serve until the 2027 annual meeting. Mr. Ferrera, a veteran CFO, will also join the Audit Committee, while Mr. Krzanich brings extensive technology leadership experience from Intel and Cerence.
Inhibikase Therapeutics appointed Dr. Scott Wasserman to its Board of Directors and the Compensation Committee, effective October 19, 2026. Dr. Wasserman, currently CMO of Kailera Therapeutics and a former Amgen executive, succeeds Dennis Berman, who resigned from the Board on the same date. The change occurs as the company advances its Phase 3 IMPROVE-PAH study of IKT-001.
Apollo Global Management appointed Meyer “Micky” Malka, founder of Ribbit Capital, to its Board of Directors, effective January 1, 2027. The appointment increases the board size to 14 members, with Malka serving as an independent director. Malka brings over 30 years of experience in technology and financial services to the board.
Celanese Corporation announced that Anne P. Noonan, who was previously elected to the Board of Directors, has been appointed to the Compensation and Management Development Committee and the Nominating and Corporate Governance Committee. These committee appointments were effective as of October 15, 2026.
Renato Derraik notified Live Oak Bancshares of his resignation as Chief Information & Digital Officer of Live Oak Banking Company on October 14, 2026. His departure is effective November 6, 2026, as he leaves to pursue other endeavors.
Northern Trust Corporation has appointed Rima Qureshi, former Chief Strategy Officer of Verizon Communications, to its Board of Directors effective October 20, 2026. Ms. Qureshi will serve on the Risk and the Technology and Operations Committees and will receive compensation under the company's Non-Employee Director Compensation Plan.
Randall P. Gabe, Senior Vice President and Chief Administrative Officer of Southwest Gas Corporation, has announced his intention to retire effective on or before June 1, 2027. Until his retirement, Mr. Gabe will transition to a new role as Senior Vice President/Business Development to support the 2028 Great Basin Expansion project.
Zapata Quantum appointed Dr. Peter Shor, the pioneer of Shor's algorithm, and three other global quantum experts to its Scientific Advisory Board. The new members will advise on the company's scientific direction and the development of its Quantum Pilot hardware-agnostic platform. This move strengthens the company's technical leadership in quantum algorithm development and error correction.
Vertex Pharmaceuticals appointed Daniel Brennan to its Board of Directors, effective October 20, 2026, increasing the board size to eleven members. Mr. Brennan, the former CFO of Boston Scientific, will also serve on the Audit and Finance Committee and received an initial $400,000 restricted stock unit award.
Federal Home Loan Bank of Des Moines Leadership Change
Federal Home Loan Bank of Des Moines appointed Brett L.A. Manning as Chief Business Officer, effective October 16, 2026. Manning, a 28-year veteran of the Bank, succeeds Wil W. Osborn, who recently became the Bank's President and CEO. He will receive an annual base salary of $425,000 and is eligible for incentive awards up to 80% of his base salary.
Clearfield announced that President and CEO Cheryl Beranek will retire effective March 31, 2027, and has entered into a transition agreement to facilitate the search for her successor. Ms. Beranek will serve as CEO until a successor is appointed, after which she will remain as CEO Emeritus to assist with the transition. The company also reaffirmed its fiscal 2026 fourth quarter and full-year financial guidance.
Kenneth Canestrari, Senior Executive Vice President and Group President, will retire from TJX Companies effective April 30, 2027. He will step down as an executive officer on January 31, 2027, but remain with the company through his retirement date to assist with the transition of his responsibilities.
Suja Life, Inc. increased its board size from seven to nine members and appointed Robert B. Engel and Zahir Ibrahim as independent directors. Mr. Engel, former CEO of CoBank, will join the Audit Committee, while Mr. Ibrahim brings CFO experience from brands including Annie’s, KIND, and BARK. Both directors were designated by affiliates of Paine Schwartz Partners under an existing agreement.
PDS Biotechnology announced a significant board reconstitution with the immediate resignation of four directors (Kamil Ali-Jackson, Stephen Glover, Gregory Freitag, and Otis Brawley) and the appointment of three new directors: Deborah A. Ramsdell, John A. Dawson CBE, and Bruce Wendel. The new appointees bring extensive experience in drug development, commercialization, and regulatory affairs as the company prepares for Phase 3 trials of PDS0301.
StubHub Holdings, Inc. appointed Andrew Raab, Co-Founder of FPR Partners, to its Board of Directors to fill an existing vacancy. Mr. Raab will receive compensation under the company's standard non-employee director program and previously entered into a three-year consulting agreement with the company in March 2026. The appointment is effective immediately with a term expiring at the 2027 annual meeting of stockholders.
Insmed Incorporated appointed Paul Hudson, former CEO of Sanofi and Novartis, and Utpal Koppikar, CFO of Verily Health, to its Board of Directors effective October 19, 2026. Both directors will receive an annual cash retainer of $65,000 plus committee fees and an initial RSU grant valued at approximately $585,000. The appointments add significant global biopharma leadership and financial expertise to the board as the company advances its rare disease pipeline.
Adam Ciongoli will step down as Chief Legal and Policy Officer effective December 1, 2026, transitioning to a special advisor role through June 2028. Nicholas Trutanich, currently Executive Vice President and Deputy General Counsel, has been appointed as the new General Counsel effective December 1, 2026. The transition includes a separation agreement for Ciongoli involving a $12.6 million cash payment for equity cancellation and a new employment agreement for Trutanich with a $1.4 million base salary.
David Yablunosky has stepped down as CFO, Principal Financial Officer, and Principal Accounting Officer of Innventure, Inc. effective October 19, 2026. He is succeeded by Eric Stober, while Chief Growth Officer Roland Austrup will also depart the company on October 31, 2026, as part of a consolidation of finance and communications functions.
Daniel Brown resigned as President & CEO and board member of Chord Energy effective October 19, 2026, to pursue another professional opportunity. The board appointed Michael Lou, the company's former Chief Strategy Officer and former CFO, as the new President & CEO and director to fill the vacancy.
CytoDyn appointed Robert E. Hoffman as Chief Executive Officer, effective October 20, 2026, succeeding Dr. Jacob Lalezari. Dr. Lalezari resigned from the CEO role but will remain with the company as Head of Research and Translational Sciences. Mr. Hoffman, who previously served as the company's CFO, will also continue to serve as the principal accounting officer.
ProPetro Holding Corp. appointed Kyle Crowley to its Board of Directors as an independent director, effective October 16, 2026. Mr. Crowley, a former senior executive at Exelon Corporation, will also serve as an audit committee financial expert. The appointment coincides with an increase in the size of the Board.
Ball Corporation announced that Carey Causey has been appointed President of Beverage Packaging North and Central America, succeeding Kathleen Pitre. Additionally, Scott A. Vail will succeed Mandy Glew as President of Beverage Packaging EMEA effective January 1, 2027, following Glew's retirement. These changes involve internal promotions of the company's current Chief Growth Officer and Chief Supply Chain and Operations Officer.
Mineralys Therapeutics appointed Kristine Peterson and Lonnel Coats to its Board of Directors, effective October 19, 2026, increasing the board size from seven to nine members. Both new directors will receive standard non-employee director compensation, including initial grants of 16,600 stock options and 12,400 restricted stock units each.
Samantha L. Stoddard is resigning as EVP and CFO of JELD-WEN effective November 13, 2026, to pursue an opportunity outside the industry. Jeffrey Embt, the current Chief Accounting Officer, has been appointed Interim CFO while the company searches for a permanent successor. The company also reaffirmed its full-year 2026 financial guidance.
Jason Cardew will resign as Senior Vice President and CFO effective February 28, 2027, and retire from the company at the end of 2027. Jared Fedele, a 23-year company veteran currently serving as VP of Finance for Seating and E-Systems, has been appointed to succeed him as CFO effective March 1, 2027. Fedele will receive an initial base salary of $750,000 and participate in the company's incentive plans.